buthionine sulfoximine has been researched along with EHS Tumor in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burt, ME; Hochwald, SN; Port, JL; Wang, HY | 1 |
| Beyers, KL; Siemann, DW | 1 |
| Chaplin, DJ; Minchinton, AI | 1 |
| Mashiba, H; Matsunaga, K | 1 |
| Hauser, GJ; McIntosh, JK; Rosenberg, SA; Travis, WD | 1 |
| Allalunis-Turner, MJ; Lee, FY; Siemann, DW | 1 |
6 other study(ies) available for buthionine sulfoximine and EHS Tumor
| Article | Year |
|---|---|
Buthionine sulfoximine pretreatment potentiates the effect of isolated lung perfusion with doxorubicin.
Topics: Animals; Antimetabolites, Antineoplastic; Buthionine Sulfoximine; Chemotherapy, Cancer, Regional Perfusion; Doxorubicin; Drug Synergism; Glutathione; Hydroxyethyl Starch Derivatives; Liver; Lung Neoplasms; Male; Methionine Sulfoximine; Rats; Rats, Inbred F344; Sarcoma, Experimental | 1995 |
In vivo therapeutic potential of combination thiol depletion and alkylating chemotherapy.
Topics: Alkylating Agents; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Cells; Buthionine Sulfoximine; Cell Survival; Chromatography, High Pressure Liquid; Colony-Forming Units Assay; Drug Resistance; Female; Glutathione; Hematopoietic Stem Cells; Melphalan; Methionine Sulfoximine; Mice; Mice, Inbred C3H; Sarcoma, Experimental | 1993 |
Spatial characterization of glutathione depletion in the KHT sarcoma using flow cytometry.
Topics: Animals; Buthionine Sulfoximine; Female; Glutathione; Methionine Sulfoximine; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Radiation Tolerance; Sarcoma, Experimental | 1991 |
[Augmentation of TNF- and lymphotoxin-mediated cytotoxic effect in the combined use of ACNU and involvement of oxygen free radicals].
Topics: Animals; Buthionine Sulfoximine; Drug Screening Assays, Antitumor; Drug Synergism; Free Radicals; Glutathione; Glutathione Reductase; Lymphotoxin-alpha; Methionine Sulfoximine; Mice; Nimustine; Oxygen; Recombinant Proteins; Sarcoma, Experimental; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1990 |
Manipulation of oxygen radical-scavenging capacity in mice alters host sensitivity to tumor necrosis factor toxicity but does not interfere with its antitumor efficacy.
Topics: Animals; Buthionine Sulfoximine; Female; Glutathione; Humans; Liver Neoplasms; Methionine Sulfoximine; Mice; Sarcoma, Experimental; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 1990 |
Depletion of tumour versus normal tissue glutathione by buthionine sulfoximine.
Topics: Animals; Buthionine Sulfoximine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glutathione; Mammary Neoplasms, Experimental; Methionine Sulfoximine; Mice; Mice, Inbred C3H; Sarcoma, Experimental; Time Factors; Tissue Distribution | 1987 |